This compound is a deuterated active pharmaceutical ingredient, a labeled derivative of a carbazole-based molecule where multiple hydrogen atoms have been replaced with deuterium. Its primary significance lies in its use as a research compound for pharmaceutical manufacturing and development.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1219798-86-3
Rifaximin-d6 (Major)
deuterated active pharmaceutical ingredient
Urapidil-d3 (methoxy-d3)
deuterated active pharmaceutical ingredient
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
deuterated active pharmaceutical ingredient
Triamcinolone Acetonide-D6
deuterated active pharmaceutical ingredient
Donepezil-d4 (hydrochloride)
active pharmaceutical ingredient
HYDROCHLOROTHIAZIDE-3,3-D2
active pharmaceutical ingredient
Propafenone (D7 hydrochloride)
active pharmaceutical ingredient
Betaxolol-d7 (hydrochloride)
Active pharmaceutical ingredient
3-[[4,5-dideuterio-2-(trideuteriomethyl)imidazol-1-yl]methyl]-9-methyl-2,3-dihydro-1H-carbazol-4-one
FELGMEQIXOGIFQ-OIYGLIEASA-N
[2H]C1=C(N(C(=N1)C([2H])([2H])[2H])CC2CCC3=C(C2=O)C4=CC=CC=C4N3C)[2H]
—